Dare Bioscience, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Dare Bioscience, Inc. (DARE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.15 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Dare Bioscience, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 4.15M shares, a 73.79% increase year-over-year.
- Dare Bioscience, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.36M shares, a 40.72% increase year-over-year.
- Dare Bioscience, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 2.68M shares, a 23.28% increase year-over-year.
- Dare Bioscience, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 2.39M shares, a 10.41% increase year-over-year.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 4.15M shares 10-Q · filed 2026-08-13 | 4.15M shares 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | 3.36M shares 10-Q · filed 2026-05-14 | |||||
| 2025-09-30 | 2.68M shares 10-Q · filed 2025-11-13 | 2.68M shares 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | 2.39M shares 10-Q · filed 2026-08-13 | 2.39M shares 10-Q · filed 2026-08-13 | ||||
| 2025-03-31 | 2.39M shares 10-Q · filed 2026-05-14 | |||||
| 2024-09-30 | 2.17M shares 10-Q · filed 2025-11-13 | 2.15M shares 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | 2.17M shares 10-Q · filed 2025-08-14 | 2.16M shares 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | 2.26M shares 10-Q · filed 2025-05-13 | 26.88M shares 10-Q · filed 2024-05-14 | ||||
| 2023-09-30 | 1.62M shares 10-Q · filed 2024-11-14 | 19.47M shares 10-Q · filed 2023-11-09 | 1.62M shares 10-Q · filed 2024-11-14 | 19.47M shares 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | 789.73K shares 10-Q · filed 2024-08-12 | 9.48M shares 10-Q · filed 2023-08-10 | 789.73K shares 10-Q · filed 2024-08-12 | 9.48M shares 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | 9.12M shares 10-Q · filed 2024-05-14 | |||||
| 2022-09-30 | 7.99M shares 10-Q · filed 2023-11-09 | 7.99M shares 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | 7.11M shares 10-Q · filed 2023-08-10 | 7.80M shares 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | 7.66M shares 10-Q · filed 2023-05-11 | |||||
| 2021-09-30 | 6.45M shares 10-Q · filed 2022-11-10 | 6.45M shares 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | 6.51M shares 10-Q · filed 2022-08-09 | 6.51M shares 10-Q · filed 2022-08-09 | ||||
| 2021-03-31 | 6.17M shares 10-Q · filed 2022-05-12 | |||||
| 2020-09-30 | 4.69M shares 10-Q · filed 2021-11-10 | 4.69M shares 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | 4.80M shares 10-Q · filed 2021-08-12 | 4.80M shares 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | 4.62M shares 10-Q · filed 2021-05-13 | |||||
| 2019-09-30 | 5.58M shares 10-Q · filed 2020-11-12 | 5.58M shares 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | 5.94M shares 10-Q · filed 2020-08-12 | 5.94M shares 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | 5.94M shares 10-Q · filed 2020-05-14 | |||||
| 2018-09-30 | 5.36M shares 10-Q · filed 2019-11-12 | 5.36M shares 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | 4.30M shares 10-Q · filed 2019-08-14 | 4.30M shares 10-Q · filed 2019-08-14 | ||||
| 2018-03-31 | 4.29M shares 10-Q · filed 2019-05-14 | |||||
| 2017-09-30 | 576.14K shares 10-Q · filed 2018-11-13 | 576.14K shares 10-Q · filed 2018-11-13 | ||||
| 2017-06-30 | 10.52K shares 10-Q · filed 2018-08-13 | 10.52K shares 10-Q · filed 2018-08-13 | ||||
| 2017-03-31 | 10.15K shares 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |